Martin-Martin, Natalia
Garcia-Longarte, Saioa
Corres-Mendizabal, Jon
Lazcano, Uxue
Astobiza, Ianire
Bozal-Basterra, Laura
Herranz, Nicolas
van Splunder, Hielke
Carlevaris, Onintza
Pujana-Vaquerizo, Mikel
Blasco, María Teresa
Aransay, Ana M.
Rosino, Antonio
Tudela, Julian
Jimenez, Daniel
Martinez, Alberto
Salca, Andrei
Santos-Martín, Aida
Rey, Sofía
Ugalde-Olano, Aitziber
Gonzalo, David
Graupera, Mariona
Gomis, Roger R.
Mateo, Joaquin
Unda, Miguel
Gonzalez-Billalabeitia, Enrique
Loizaga-Iriarte, Ana
Mendizabal, Isabel
Carracedo, Arkaitz
Funding for this research was provided by:
AECC (GCTRA18006CARR, GCTRA18006CARR, GCTRA18006CARR, GCTRA18006CARR, GCTRA18006CARR)
CRIS Cancer, Spain (PR_TPD_2020-19)
MCIN (RYC2023-044682-I)
HORIZON EUROPE European Research Council (Consolidator Grant 819242)
Article History
Received: 7 August 2024
Accepted: 16 May 2025
First Online: 3 June 2025
Declarations
:
: The ethics approvals for this project are CEIC-E 14–14 and 19–20 (Basurto University Hospital, Bilbao), CEIC-HMM 1/18 (Morales Meseguer University Hospital, Murcia) and PRAG5248 (Vall d’Hebron University Hospital, Barcelona, under IRB-approval). See Methods section for more details. Animal experiments have been approved by CIC bioGUNE Ethics committee and the local authorities with codes P-CBG-CBBA-0121 and P-CBG-CBBA-1321.
: Not applicable.
: The authors declare no competing interests.